Hemoperfusion for phenylbutazone poisoning. 1982

W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh

UI MeSH Term Description Entries
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
December 2018, Kidney international,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
February 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
November 1992, Critical care medicine,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
December 1988, Revista clinica espanola,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
May 1986, Klinische Wochenschrift,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
January 1993, Klinische Anasthesiologie und Intensivtherapie,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
August 1991, Ugeskrift for laeger,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
April 1983, Journal of toxicology. Clinical toxicology,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
July 1981, Clinical chemistry,
W G Berlinger, and R Spector, and M J Flanigan, and G F Johnson, and M R Groh
January 1970, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!